Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breaking news from “The Pink Sheet” DAILY

Executive Summary

Visit 1www.ThePinkSheetDAILY.com for coverage of the latest developments in the pharmaceutical industry, including the approval of Bristol-Myers Squibb/Otsuka's antipsychotic Abilify for use in acute bipolar mania, J&J's subpoena from the HHS Inspector General requesting documents relating to its sales and marketing of Procrit and Gov. Schwarzenegger's vetoes of California importation legislation. To sign up for a free trial of "The Pink Sheet" DAILY, visit our website or call customer service at 800-332-2181...

You may also be interested in...



Executives On The Move: New CEO Appointed At Xwpharma

New directors at 4D Pharma, Neurogene And Zogenix.

Improve Access to RWD In Asia To Make RWE Viable

Industry access to real world data for regulatory and market access purposes in Asia Pacific compares poorly with the US.

Inflexion Outlines Rosemont Investment And Eyes More Generics Deals

In an exclusive interview with Generics Bulletin, Inflexion’s Ben Long reveals his ambitions for newly-acquired UK-based liquids generics specialist Rosemont Pharmaceuticals, including to drive investment in R&D and expand the company’s international footprint.

UsernamePublicRestriction

Register

PS142970

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel